DTL
DAWN

Dynamic Technology Lab’s Day One Biopharmaceuticals DAWN Stock Holding History

Dynamic Technology Lab’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-87,541
Closed -$618K – 831
2025
Q3 		$618K Buy
87,541
+4,318
+5% +$29.7K 0.1% 337
2025
Q2 		$541K Buy
83,223
+34,766
+72% +$239K 0.07% 474
2025
Q1 		$384K Buy
+48,457
New +$522K 0.06% 595
2024
Q4 		– Sell
-12,474
Closed -$174K – 999
2024
Q3 		$174K Buy
+12,474
New +$178K 0.02% 896
2024
Q1 		– Sell
-10,651
Closed -$156K – 1119
2023
Q4 		$156K Buy
+10,651
New +$129K 0.02% 911
2023
Q3 		– Sell
-23,355
Closed -$279K – 1025
2023
Q2 		$279K Sell
23,355
-17,796
-43% -$232K 0.04% 736
2023
Q1 		$550K Buy
+41,151
New +$804K 0.05% 589

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's DAWN Position: Q4 2025 in Review

Dynamic Technology Lab sold out of Day One Biopharmaceuticals (DAWN) in Q4 2025, closing a stake of 87,541 shares — an estimated $618K sold.

Dynamic Technology Lab first reported a position in DAWN in Q1 2023 and held it in 7 quarters. The position peaked at $618K in Q3 2025. 183 funds tracked by Wall St. Rank hold DAWN as of Q4 2025.

  • Dynamic Technology Lab reported no remaining Day One Biopharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 87,541 Day One Biopharmaceuticals shares in Q4 2025, an estimated $618K.
  • Dynamic Technology Lab first reported a position in Day One Biopharmaceuticals in Q1 2023 and held it in 7 quarters.
  • Dynamic Technology Lab's Day One Biopharmaceuticals position peaked at $618K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2025.

Based on Dynamic Technology Lab's 13F filing for Q4 2025, filed 13 Feb 2026.